BackCSPC Pharmaceutical Group Limited. Overview

CSPC Pharmaceutical Group Limited. Minority Interest

CSPC Pharmaceutical Group Limited.'s minority interest is $1.8B.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$1.81B
11.99% YoYΔ $193.56M vs prior year quarter

Peer trimmed avg / median

Loading

CSPC Pharmaceutical Group Limited. Minority Interest History

Loading

CSPC Pharmaceutical Group Limited. vs. peers: Minority Interest Comparison

Loading

CSPC Pharmaceutical Group Limited. Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

CSPC Pharmaceutical Group Limited. (CSPCY) FAQ

As of the most recent data (June 2026), CSPCY shows a minority interest of $1.8B. That compares with $1.6B in the prior-year period — up 12.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CSPCY's minority interest is now $1.8B (was $1.6B) — a 12.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether CSPC Pharmaceutical Group Limited. is outperforming or lagging.

Tracking CSPCY's minority interest over time shows whether CSPC Pharmaceutical Group Limited. is scaling, shrinking, or reshaping that part of the business. The current reading is $1.8B That compares with $1.6B in the prior-year period — up 12.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has CSPC Pharmaceutical Group Limited.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $1.8B) with ownership activity and broader fundamentals.

CSPC Pharmaceutical Group Limited.'s minority interest is $1.8B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.